Instead of leading the rush to find and mass manufacture a vaccine or lifesaving treatment, two of the sites are taking no role, while the other two expect to conduct small-scale testing of potential coronavirus vaccines.At a cost to date of nearly $670 million, the Department of Health and Human Services and the Pentagon awarded contracts beginning in 2012 and 2013 to build or expand the four manufacturing complexes. Proponents said the sites would work with three private companies and one university to deliver emergency medicines and treatments, including flu vaccine, for both the military and civilians.A Defense Department statement on Sept. 1, 2011, said its plant, which was eventually located in Alachua, Fla., would provide medical countermeasures and meet the military’s needs with “capabilities to rapidly respond” to “emerging and genetically engineered infectious disease outbreaks.’’The three new HHS-backed sites, in Baltimore, College Station, Tex., and Holly Springs, N.C., would use modern “vaccine technologies that have the potential to produce vaccines for not only pandemic influenza but also other threats more quickly and in a more affordable way,’’ according to an agency news release on June 18, 2012.The facilities, HHS said, “will provide the first major domestic infrastructure in the

Continue To Full Article